| Literature DB >> 28596969 |
Tetsuya Ikeda1, Kimiya Shimizu1, Akihito Igarashi1, Sumie Kasahara1, Kazutaka Kamiya1.
Abstract
PURPOSE: To assess the long-term clinical outcomes of conventional laser in situ keratomileusis (LASIK) for moderate to high myopia.Entities:
Mesh:
Year: 2017 PMID: 28596969 PMCID: PMC5449750 DOI: 10.1155/2017/9391436
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Preoperative demographics of the study population undergoing conventional laser in situ keratomileusis (LASIK).
| Characteristic | Mean ± standard deviation |
|---|---|
| Age (years) | 34.4 ± 9.5 years (range, 23 to 58 years) |
| Gender (% female) | 63.2% |
| Manifest spherical equivalent (D) | −6.70 ± 2.52 D (range, −3.00 to −12.75 D) |
| Manifest cylinder (D) | 0.76 ± 0.67 D (range, 0.00 to 3.00 D) |
| LogMAR UDVA | 1.32 ± 0.22 (range, 0.82 to 2.00) |
| LogMAR CDVA | −0.10 ± 0.05 (range, −0.18 to 0.00) |
| Mean keratometric readings (D) | 43.6 ± 1.3 D (range, 40.5 to 47.4 D) |
| Central cornea thickness ( | 545.4 ± 30.6 |
| Intraocular pressure (mmHg) | 15.0 ± 2.3 mmHg (range, 9 to 20 mmHg) |
| Endothelial cell density (cells/mm2) | 2725 ± 265 cells/mm2 (range, 1990 to 3246 cells/mm2) |
D = diopter, LogMAR = logarithm of the minimal angle of resolution, UDVA = uncorrected distance visual acuity, and CDVA = corrected distance visual acuity.
Figure 1Changes in corrected distance visual acuity (CDVA) 12 years after laser in situ keratomileusis (LASIK). Group 1 is low to moderate myopia group and Group 2 is high myopia group.
Figure 2Cumulative percentages of eyes attaining uncorrected distance visual acuity (UDVA) of 20/20 or more 12 years after laser in situ keratomileusis (LASIK). Group 1 is low to moderate myopia group and Group 2 is high myopia group.
Figure 3Percentages of eyes within ±1.0 D of the attempted (spherical equivalent) correction after laser in situ keratomileusis (LASIK). Group 1 is low to moderate myopia group and Group 2 is high myopia group.
Figure 4A scatter plot of the attempted versus the achieved manifest spherical equivalent correction 12 years after laser in situ keratomileusis (LASIK). Group 1 is low to moderate myopia group and Group 2 is high myopia group.
Figure 5Time course of manifest spherical equivalent after laser in situ keratomileusis (LASIK). Group 1 is low to moderate myopia group and Group 2 is high myopia group.
Figure 6A graph showing a significant correlation between the change in mean keratometric readings and the changes in spherical equivalent from 3 month to 12 years after laser in situ keratomileusis (LASIK). Group 1 is low to moderate myopia group and Group 2 is high myopia group.
Summary for long-term clinical outcomes of conventional laser in situ keratomileusis (LASIK).
| Author Year | Excimer laser | Eyes | Follow-up (years) | Mean Age (years) | Mean spherical equivalent (D) | Safety index | Efficacy index | Predictability | Myopic regression (D) | Retreatment (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| Alió et al. 2009 | VISX 20/20 | 34 | 10 | 29.4 | −8.30 | 1.11 | 0.95 | 88 | −0.97 | 18 |
| Alió et al. 2008 | VISX 20/20 | 97 | 10 | 33.2 | −7.27 | 1.08 | 0.88 | 73 | −1.04 | 20.6 |
| Alió et al. 2008 | VISX 20/20 | 196 | 10 | 32.9 | −13.95 | 1.21 | 0.77 | 42 | −1.83 | 27.5 |
| Kymionis et al. 2007 | MEL 60 | 11 | 11 | 41.7 | −12.96 | N.A. | N.A. | 55 | −1.14 | 0 |
| Rosman et al. 2011 | VISX 20/20 | 126 | 10 | 33.7 | −14.33 | 1.20 | 0.84 | 42 | −1.86 | 28.6 |
| Oruçoğlu et al. 2012 | Keracor | 36 | ≥10 | N.A. | −21.7 | 1.48 | 0.29 | 10 | −6.09 | N.A. |
| Alió et al. 2015 | VISX 20/20 | 40 | 15 | 51.1 | −9.47 | 1.23 | 0.95 | 46 | −1.66 | 30.8 |
| Lim et al. 2016 | VISX S4 | 36 | 10 | 26.6 | −5.73 | 0.99 | 0.73 | 68 | −1.09 | 0 (excluded) |
| Current | VISX STAR S2 | 68 | 12 | 34.4 | −6.70 | 1.09 | 0.67 | 75 | −0.74 | 17.6 |
D = diopter, N.A. = not applicable.